When Amylyx Pharmaceuticals found out its ALS drug Relyvrio didn’t work, the company took the unusual step of voluntarily pulling it off the market.
When Amylyx Pharmaceuticals found out its ALS drug Relyvrio didn’t work, the company took the unusual step of voluntarily pulling it off the market.